Drug Information Association Logo
« Back to Listing

Effective Leadership in Hybrid Team Between West and East Asia in New Drug Development

Track:
Project/Portfolio Management and Strategic Planning

Day & Time:
June 17, 8:00AM - 9:30AM (Pacific Standard Time)

Session Number:
205

Room Number:
1A

Level:
Basic

Type:
Forum

Title:
Effective Leadership in Hybrid Team Between West and East Asia in New Drug Development

Chair(s):
Atsushi Tsukamoto, PhD, MSc, PMP
Senior Director, Global Project Management
Daiichi Sankyo Company, Ltd., Japan

Description:
In this forum, we will discuss key success factors and common gaps in a West and East Asian hybrid team in drug development. Participants will learn practical tips that can be used immediately for successful hybrid team leadership and management.

Learning Objective(s):
Effectively lead and manage a West and East Asian hybrid drug development team; Discuss various leadership models in a hybrid team; Discuss strengths and weaknesses of a hybrid team, especially a West and East Asian hybrid; Identify success factors for Western colleagues to effectively work with Korean, Chinese and Japanese organizations in a global environment.

Presentation(s) & Speaker(s):
Panelist
Robert A. Hilke, MA
Chief Executive Officer
Hilke Communications Corporation, Japan

Panelist
Gareth Julian Monteath, MBA, MS
Program Director
Link Global Solution Inc., Japan

Panelist
Atsushi Tsukamoto, PhD, MSc, PMP
Senior Director, Global Project Management
Daiichi Sankyo Company, Ltd., Japan